Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables

Value{"unit": "CHF", "value": -103601}
Period2022-01-01 – 2022-12-31
Statussuperseded
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-24-034940
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/908c73cc-baba-4dc5-9e66-68956575b6d6

History